|
HY-126037-1mg
|
MedChemexpress LLC
|
(�)-ML 209 [CAS 1334526-14-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-132135-1mg
|
MedChemexpress LLC
|
(1E)-CFI-400437 (dihydrochloride) [CAS 1247000-76-5]
|
|
Cancer-Kinase/protease
|
|
|
HY-132135-10mg
|
MedChemexpress LLC
|
(1E)-CFI-400437 (dihydrochloride) [CAS 1247000-76-5]
|
|
Cancer-Kinase/protease
|
|
|
HY-132135-100mg
|
MedChemexpress LLC
|
(1E)-CFI-400437 (dihydrochloride) [CAS 1247000-76-5]
|
|
Cancer-Kinase/protease
|
|
|
HY-132135-25mg
|
MedChemexpress LLC
|
(1E)-CFI-400437 (dihydrochloride) [CAS 1247000-76-5]
|
|
Cancer-Kinase/protease
|
|
|
HY-132135-5mg
|
MedChemexpress LLC
|
(1E)-CFI-400437 (dihydrochloride) [CAS 1247000-76-5]
|
|
Cancer-Kinase/protease
|
|
|
HY-132135-50mg
|
MedChemexpress LLC
|
(1E)-CFI-400437 (dihydrochloride) [CAS 1247000-76-5]
|
|
Cancer-Kinase/protease
|
|
|
HY-14291B-1mg
|
MedChemexpress LLC
|
(2R)-Vildagliptin [CAS 1036959-27-9]
|
|
|
|
|
HY-14291B-10mg
|
MedChemexpress LLC
|
(2R)-Vildagliptin [CAS 1036959-27-9]
|
|
|
|
|
HY-14291B-5mg
|
MedChemexpress LLC
|
(2R)-Vildagliptin [CAS 1036959-27-9]
|
|
|
|
|
HY-108444A-1mg
|
MedChemexpress LLC
|
(E)-FeCP-oxindole [CAS 884338-18-5]
|
|
|
|
|
HY-125263B-1mg
|
MedChemexpress LLC
|
(R)-OP-1074 [CAS 1443752-77-9]
|
|
|
|
|
HY-125263B-10mg
|
MedChemexpress LLC
|
(R)-OP-1074 [CAS 1443752-77-9]
|
|
|
|
|
HY-125263B-25mg
|
MedChemexpress LLC
|
(R)-OP-1074 [CAS 1443752-77-9]
|
|
|
|
|
HY-125263B-5mg
|
MedChemexpress LLC
|
(R)-OP-1074 [CAS 1443752-77-9]
|
|
|
|
|
HY-136285A-10mg
|
MedChemexpress LLC
|
(R,R)-CPI-1612 [CAS 2374972-35-5]
|
|
|
|
|
HY-136285A-25mg
|
MedChemexpress LLC
|
(R,R)-CPI-1612 [CAS 2374972-35-5]
|
|
|
|
|
HY-136285A-5mg
|
MedChemexpress LLC
|
(R,R)-CPI-1612 [CAS 2374972-35-5]
|
|
|
|
|
HY-144841A-10mg
|
MedChemexpress LLC
|
(Rac)-Cemsidomide [CAS 2504233-68-3]
|
|
Cancer-programmed cell death
|
|
|
HY-144841A-5mg
|
MedChemexpress LLC
|
(Rac)-Cemsidomide [CAS 2504233-68-3]
|
|
Cancer-programmed cell death
|
|
|
HY-144841A-1mL
|
MedChemexpress LLC
|
(Rac)-Cemsidomide [CAS 2504233-68-3] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-B0203B-10mg
|
MedChemexpress LLC
|
(Rac)-Nebivolol [CAS 99200-09-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-B0203B-5mg
|
MedChemexpress LLC
|
(Rac)-Nebivolol [CAS 99200-09-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-119486A-10mg
|
MedChemexpress LLC
|
(Rac)-Tavapadon [CAS 1643462-64-9]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-119486A-100mg
|
MedChemexpress LLC
|
(Rac)-Tavapadon [CAS 1643462-64-9]
|
|
Neuroscience-Neurodegeneration
|
|
